Cargando…
Regulatory Framework for Academic Investigator-Sponsored Investigational New Drug Development of Cell and Gene Therapies in the USA
PURPOSE OF REVIEW: The promise of cell and gene therapy (CGT) products for a multitude of diseases has revitalized investigators to advance novel CGT product candidates to first-in-human trials by pursuing the investigational new drug (IND) mechanism administered by the United States (US) Food and D...
Autores principales: | Dasgupta, Anindya, Herzegh, Kristen, Spencer, H. Trent, Doering, Christopher, Day, Eric, Swaney, William P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483165/ https://www.ncbi.nlm.nih.gov/pubmed/34608428 http://dx.doi.org/10.1007/s40778-021-00196-4 |
Ejemplares similares
-
Immune Editing: Overcoming Immune Barriers in Stem Cell Transplantation
por: Meissner, Torsten B., et al.
Publicado: (2022) -
Impact of Cryopreservation and Freeze-Thawing on Therapeutic Properties of Mesenchymal Stromal/Stem Cells and Other Common Cellular Therapeutics
por: Cottle, Chasen, et al.
Publicado: (2022) -
RNA sequencing of the nephron transcriptome: a technical note
por: Lee, Jae Wook
Publicado: (2015) -
Organ-on-a-chip and the kidney
por: Kim, Sejoong, et al.
Publicado: (2015) -
Establishment of Immortalized BMP2/4 Double Knock‐Out Osteoblastic Cells Is Essential for Study of Osteoblast Growth, Differentiation, and Osteogenesis
por: Wu, Li‐An, et al.
Publicado: (2015)